Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Desmopressin (0.1mg) Tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Desmopressin 0.1mg tablet is a synthetic vasopressin analog used for managing diabetes insipidus, nocturnal polyuria, and related urinary disorders.
It works by reducing urine production through its antidiuretic effect, helping patients maintain fluid balance and reduce excessive urination, especially during the night.
This tablet is widely prescribed in central diabetes insipidus, nocturia in adults, and patients with urinary frequency disorders, improving quality of life and daily convenience.
With strong clinical importance in endocrinology and urology care, consistent physician trust, and growing demand in urinary management therapy, this formulation strengthens institutional and outpatient therapy portfolios and supports sustained therapeutic utilization.
Some patients may experience headache, mild nausea, abdominal discomfort, or water retention. Rarely, hyponatremia (low sodium levels) or allergic reactions may occur and require medical attention. Symptoms like swelling, confusion, or unusual fatigue should be reported immediately.
Desmoprin 0.1 Tablet is indicated for the treatment of nocturnal enuresis (bedwetting) in children and adults, central diabetes insipidus, and other conditions characterized by excessive urination due to deficient antidiuretic hormone activity.
This medicine should be taken under medical supervision. Patients with kidney problems, heart disease, or electrolyte imbalances should consult a healthcare professional before use. Strict adherence to dosage instructions is necessary to avoid water retention or electrolyte disturbances.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Paracetamol (100mg)
Composition : Cyproheptadine (1.5mg) + Tricholine Citrate (55mg)
Composition : Hydroxyzine (6mg) Drops
Composition : Chlorpheniramine Maleate (1mg) + Paracetamol (125mg) + Phenylephrine (2.5mg)
Composition : Chlorpheniramine Maleate (2mg) + Phenylephrine (5mg) (Banned)
Composition : Olopatadine (0.1% w/v) eye drop
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation